Q4FY26 & FY26 Result Announced for Viyash Scientific Ltd.

Q4FY26 & FY26 Result Announced for Viyash Scientific Ltd. $VIYASH Pharmaceuticals company Viyash Scientific announced Q4FY26 & FY26 results Consolidated Financial Highlights Revenue from Operations: Consolidated revenue for Q4FY26 was Rs 9,199.60 million, up 7.17% QoQ from Rs 8,584.10 million and up 19.12% YoY from Rs 7,723.10 million. For the full year FY26, revenue was Rs 34,203.10 million, an increase of 13.75% YoY from Rs 30,068.40 million in FY25. Total Income: Consolidated total income for Q4FY26 reached Rs 9,358.80 million, a growth of 7.28% QoQ and 19.59% YoY. Annual total income for FY26 stood at Rs 34,638.60 million compared to Rs 30,397.30 million in FY25. Profit Before Tax (PBT): Consolidated PBT for Q4FY26 was Rs 1,252.40 million, up 71.40% QoQ from Rs 730.70 million and a significant turnaround from a loss of Rs 366.60 million in Q4FY25. For the full year FY26, PBT grew to Rs 3,490.20 million from Rs 131.80 million in FY25. Net Profit After Tax (PAT): Consolidated net profit for Q4FY26 was Rs 663.80 million, up 36.81% QoQ from Rs 485.20 million and a turnaround from a loss of Rs 321.80 million in Q4FY25. For the full year FY26, consolidated PAT reached Rs 2,246.50 million, marking a massive increase from Rs 157.70 million in FY25. Total Comprehensive Income: Consolidated total comprehensive income for FY26 was Rs 3,315.50 million compared to Rs 308.00 million in FY25. Earnings Per Share (EPS): Consolidated basic EPS for FY26 grew to Rs 4.09 from Rs 0.54 in FY25. All this is for information. This is not a buy/sell recommendation. Thank you, Technofunda24